tm logo
Trademark Search
CATALENT XPRESS PHARMACEUTICS

View On IC.GC.CA

CATALENT XPRESS PHARMACEUTICS
SEARCHED

on 20 Feb 2024

Last Applicant/ Owned by

CATALENT PHARMA SOLUTIONS INC.

14 Schoolhouse RoadSomerset NJ 08873

US

Serial Number

2220067 filed on 27th Sep 2022

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

CATALENT XPRESS PHARMACEUTICS

Trademark usage description

custom manufacture of pharmaceuticals, biopharmaceuticals, and oral drug formulations; manufacturing process consulting. pharmaceutical drug developm Read More

Classification Information

Class [040]
Custom manufacture of pharmaceuticals, biopharmaceuticals, and oral drug formulations; manufacturing process consulting.

Classification kind code

11

Class [042]
Pharmaceutical drug development services; pharmaceutical research and development; research and development in the field of oral drug formulations and drug dosage for clinical studies; scientific and technological services, namely, scientific research, analysis, and clinical testing in the field of pharmaceuticals, biopharmaceuticals, oral drug formulations and drug dosage; scientific research and development; consulting services for others in the field of designing clinical trials.

Classification kind code

11

Mark Details

Serial Number

2220067

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 20th Feb 2024		Search Recorded
Submitted for opposition 20
on 20th Feb 2024		Examiner's First Report
Submitted for opposition 223
on 20th Feb 2024		Total Provisional Refusal
Submitted for opposition 256
on 05th Sep 2023		Notification of Possible Opposition Sent
Submitted for opposition 48
on 16th Nov 2022		Agent Changed
Submitted for opposition 257
on 03rd Nov 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 03rd Nov 2022		Formalized
Submitted for opposition 1
on 03rd Nov 2022		Created
Submitted for opposition 228
on 27th Sep 2022		International Registration
Submitted for opposition 30
on 27th Sep 2022		Filed